J.P. Leroux
- Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism 16
- Clinical Biochemistry top 0.5%
- Metabolism and Genetic Disorders 13
- Biochemistry top 2%
- Eicosanoids and Hypertension Pharmacology 6
- Amino Acid Enzymes and Metabolism 4
- Oncology top 10%
- Drug Transport and Resistance Mechanisms 8
- Molecular Biology top 10%
- Mitochondrial Function and Pathology 4
-
- Erythrocyte Function and Pathophysiology 6
- Diet and metabolism studies 5
- Co-authors
- Philippe BeauneIsabelle de WaziersPaul‐Henri CugnencChunsong YangP CartierClaude CepanecFrance DemaugreJean-Pierre Flinois
- Journals
- Biochemical and Biophysical Research Communications (5 papers)Clinica Chimica Acta (2 papers)Journal of Mass Spectrometry (2 papers)
- Partner nations
- FranceCanadaUnited States
In The Last Decade
J.P. Leroux
45 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 99
- Pharmacology 679
- Clinical Biochemistry 475
- Biochemistry 213
- Oncology 392
- Molecular Biology 842
Countries citing papers authored by J.P. Leroux
This map shows the geographic impact of J.P. Leroux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.P. Leroux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.P. Leroux more than expected).
Fields of papers citing papers by J.P. Leroux
This network shows the impact of papers produced by J.P. Leroux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.P. Leroux. The network helps show where J.P. Leroux may publish in the future.
Co-authorship network
The 25 scholars most cited alongside J.P. Leroux, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 28 | |
| 2 | 1998 | 181 | |
| 3 | 1998 | 4 | |
| 4 | 1993 | 27 | |
| 5 | 1993 | 12 | |
| 6 | 1993 | 158 | |
| 7 | 1992 | 27 | |
| 8 | 1991 | 38 | |
| 9 | 1991 | 154 | |
| 10 | 1990 | 412 | |
| 11 | 1989 | 5 | |
| 12 | 1987 | 19 | |
| 13 | 1985 | 4 | |
| 14 | 1985 | 43 | |
| 15 | 1984 | 15 | |
| 16 | 1983 | 23 | |
| 17 | 1970 | 21 | |
| 18 | [Deficiency in erythrocytic pyruvate-kinase during acute leukemia]. | 1969 | 2 |
| 19 | Caractères cinétiques de deux formes interconvertibles de pyruvate kinase dans le globule rouge humain. | 1968 | 1 |
| 20 | Techniques de dosage des enzymes glycolytiques tissulaires. | 1967 | 13 |
About J.P. Leroux
J.P. Leroux is a scholar working on Clinical Biochemistry, Pharmacology and Biochemistry, having authored 47 papers that have together received 1.9k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (16 papers), Metabolism and Genetic Disorders (13 papers), Drug Transport and Resistance Mechanisms (8 papers), Erythrocyte Function and Pathophysiology (6 papers), Eicosanoids and Hypertension Pharmacology (6 papers), Diet and metabolism studies (5 papers), Amino Acid Enzymes and Metabolism (4 papers) and Mitochondrial Function and Pathology (4 papers). The work is most often cited by research in Pharmacology (679 citations), Clinical Biochemistry (475 citations) and Biochemistry (213 citations). J.P. Leroux has collaborated with scholars based in France, Canada and United States. Frequent co-authors include Philippe Beaune, Isabelle de Waziers, Paul‐Henri Cugnenc, Chunsong Yang, P Cartier, Claude Cepanec, France Demaugre, Jean-Pierre Flinois, F. Rocchiccioli and Jean‐Paul Bonnefont. Their work appears in journals such as Biochemical and Biophysical Research Communications, Clinica Chimica Acta, Journal of Mass Spectrometry, Biochemical Journal and Biochemical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.